|
Volumn 9, Issue 2, 2002, Pages 206-212
|
Congenital toxoplasmosis: Prevention in pregnant woman and management of the newborn;Toxoplasmose congénitale: Prévention chez la femme enceinte et prise en charge du nouveau-né
a a a a a a a |
Author keywords
Clinical protocols; Congenital; Diagnosis; Toxoplasmosis
|
Indexed keywords
FANSIDAR;
FOLINATE CALCIUM;
LEDRFOLINE;
OSTOLATE;
PYRIMETHAMINE SULFADIAZINE;
SPIRAMYCIN;
AMNION FLUID;
ANTIBIOTIC THERAPY;
CONGENITAL TOXOPLASMOSIS;
DISEASE COURSE;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
PATHOPHYSIOLOGY;
PRENATAL DIAGNOSIS;
REVIEW;
SCREENING;
TOXOPLASMA GONDII;
ADULT;
AGE FACTORS;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
ANTIPROTOZOAL AGENTS;
CHILD;
COCCIDIOSTATS;
FEMALE;
HUMANS;
INFANT, NEWBORN;
PREGNANCY;
PREGNANCY COMPLICATIONS, PARASITIC;
PYRIMETHAMINE;
SPIRAMYCIN;
SULFADIAZINE;
SULFADOXINE;
TOXOPLASMOSIS;
TOXOPLASMOSIS, CONGENITAL;
|
EID: 18244401975
PISSN: 0929693X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0929-693X(01)00731-X Document Type: Review |
Times cited : (11)
|
References (26)
|